Comorbidity patterns and immune-metabolic differences in patients with acute depressive episodes

Area of Science:

• Psychiatry
• Immunology
• Metabolic Disorders

Background:

• Depression frequently co-occurs with physical and psychiatric conditions, often linked to immune and metabolic dysregulation.
• Understanding these comorbidity patterns and their biological markers is key for improved patient stratification and treatment.

Purpose of the Study:

• To identify distinct comorbidity patterns in patients with depression.
• To investigate the immune and metabolic signatures associated with each comorbidity pattern.

Main Methods:

• Retrospective analysis of electronic medical records from 7541 inpatients with depressive episodes or recurrent depressive disorder.
• Latent Class Analysis (LCA) used to identify comorbidity patterns based on 30 common conditions.
• Generalized linear models assessed differences in 12 peripheral blood immune and metabolic indicators.

Main Results:

• Four distinct comorbidity clusters were identified among depressed patients.
• Metabolic and cardiovascular comorbidity clusters showed elevated systemic inflammation (SII) and reduced HDL-C.
• Anxiety and thyroid comorbidity cluster displayed endocrine dysfunction (TSH) with suppressed inflammation (SII).
• Anxiety-only cluster exhibited downregulation of immune markers like white blood cell count.

Conclusions:

• Comorbidities in depression form distinct patterns with varying immune and metabolic characteristics.
• Patients with metabolic and cardiovascular issues present a higher inflammatory profile, necessitating cardiometabolic assessment.
• Routine blood biomarkers may help characterize clinical heterogeneity in depression.